Albertsons partnership brings ‘clinic of the future’ to Arizona Safeway stores
Two Safeway stores in the Phoenix area are kicking off a new partnership between Albertsons and Akos Med Clinic, whose artificial intelligence- and augmented reality-powered self-guided medical stations are now available to shoppers. Akos said it planned to expand the offering to 50 Safeway locations throughout Arizona by the middle of 2019, as well as to such other states as Colorado.
“Safeway is a local community grocery store and pharmacy that cares about the health and wellness of our customers,” said Joe Leyba, Albertsons director of pharmacy operations for the southwest region. “Our vision is that the Akos Med Clinic will increase access to care and help customers experience a one-stop shop for all their nutritional and medicinal needs.”
The medical station guides patients, who are sitting in front of a computer screen and a rack of medical tools, through self-administered steps to collect such data as weight, temperature, blood pressure and blood oxygen content, as well as images of their ear, nose and throat, and sounds of their chest, lungs and abdomen. The process is designed to take less than 15 minutes, and their work-up is sent, along with potential illnesses and treatment options, to an Akos provider who engages with the patient through a video consultation to confirm the collected info, verify the diagnosis and confirm or change the treatment plan. There also will be an on-site healthcare professional to assist if needed, Akos said.
The medical station, which combines Akos’ virtual health platform with AdviNow Medical’s technology, can help diagnose and treat such illnesses as sinus infections, earaches, sore throats, rashes and urinary tract infections.
“In a time when digital health is rapidly evolving, we are excited to bring this unprecedented approach to virtual medical care,” said Kishlay Anand, Akos CEO and co-founder. “At Akos, we’re committed to improving access to high-quality medical care and this partnership will expand our telehealth offering beyond the capabilities of our telemedicine app by placing these clinics where consumers regularly shop.”
Lupin launches generic nystatin, triamcinolone acetonide cream
Lupin has launched nystatin and triamcinolone acetonide cream 100,000 units/gm 0.1 %, having received an approval from the Food and Drug Administration earlier.
Lupin’s nystatin and triamcinolone acetonide cream is the generic of Taro Pharmaceuticals’ nystatin and triamcinolone acetonide cream.
The product is indicated for the treatment of cutaneous candidiasis.
Nystatin and triamcinolone acetonide cream had a market value of $54.3 million, according to September 2018 IQVIA data.
NACDS Foundation dinner brings in more than $1.8M for patient-care initiatives
The National Association of Chain Drug Stores Foundation celebrated its 20th Annual Foundation Dinner in New York City on Nov. 28, raising more than $1.8 million, which will support evidence-based research, pharmacy education and philanthropic initiatives to improve patient outcomes and advance population health.
Among the patient-health programs that NACDS Foundation supporters make possible is a collaborative program in Pennsylvania, which screens patients at pharmacies for opioid use disorder and refers those in need to appropriate care,” said NACDS chairman Mark Panzer, who is senior vice president of pharmacy, health and wellness at Albertsons.
Panzer also described a program in Washington State with a focus on improving patient care by optimizing statin therapy in patients with diabetes, based on national medical recommendations.
“Today, innovative delivery care models are emerging, which include physicians and pharmacists collaborating together. Under the leadership of the foundation’s president Kathleen Jaeger, the foundation is exploring ways to improve care coordination across healthcare teams and to advance patient care and population health,” Panzer said.
At the event, Michael Fraser, CEO of the Association of State and Territorial Health Officials, received the 2018 NACDS Foundation Excellence in Patient Care Award.
“Dr. Fraser has been advancing his organization’s mission as an advocate for state and territorial public health for the past two years,” said NACDS Foundation president Kathleen Jaeger. “He has provided distinguished leadership in addressing the opioid epidemic and in advancing maternal and children’s health, among other vital priorities. Yet, his commitment to helping all Americans lead healthy lives goes even further.”
Fraser has served as CEO of the Pennsylvania Medical Society; CEO of the Association of Maternal and Child Health Programs; and as a deputy executive director at the National Association of County and City Health Officials. He also has served in several capacities at the Department of Health and Human Services, including his work at the Centers for Disease Control and Prevention.
“He has provided a lifetime of leadership on issues that are essential to the foundation’s mission,” Jaeger said.
“For almost 12 years, I have had the opportunity to serve as chairman of the NACDS Foundation. During that time, I have had the distinct pleasure of working alongside the foundation’s talented board of directors. I am confident that the foundation has the right leadership, and the right focus,” NACDS president, CEO and NACDS Foundation chairman Steve Anderson said. “And, I’m proud to say that the continued transformation of the foundation has taken us down a path of real achievement to advance patient health. What better way to advance health than to support research that explores promising new models of care — models that can be replicated and scaled into real-world solutions.”